Cell adhesion and polarity during immune interactions

Immunological Reviews

Volumn 186, Issue , 2002, Pages 68-82

  Montoya, María C ^a   Sancho, David ^a   Vicente Manzanares, Miguel ^a   Sánchez Madrid, Francisco ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; MEMBRANE RECEPTOR;

ANTIGEN PRESENTING CELL; B LYMPHOCYTE; CELL ADHESION; CELL INTERACTION; CELL POLARITY; CELLULAR DISTRIBUTION; CONJUGATION; CYTOSKELETON; DENDRITIC CELL; EFFECTOR CELL; IMMUNE RESPONSE; LYMPHOCYTE MIGRATION; NATURAL KILLER CELL; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; ANIMAL; CELL COMMUNICATION; CYTOPLASM; CYTOTOXICITY; HUMAN; IMMUNOLOGY;

ANIMALS; ANTIGEN-PRESENTING CELLS; CELL ADHESION; CELL COMMUNICATION; CELL POLARITY; CYTOPLASM; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; KILLER CELLS, NATURAL; T-LYMPHOCYTES;

EID: 0036696402     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-065X.2002.18607.x     Document Type: Review

References (176)

1. Banchereau J, et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000; 18: 767-811.
2. Iezzi G, Karjalainen K, Lanzavecchia A. The duration of antigenic stimulation determines the fate of naive and effector T cells. Immunity 1998; 8: 89-95.
3. Iezzi G, Scottet E, Scheidegger D, Lanzavecchia A. The interplay between the duration of TCR and cytokine signaling determines T cell polarization. Eur J Immunol 1999; 29: 4092-4101.
4. Kondo T, et al. Dendritic cells signal T cells in the absence of exogenous antigen. Nat Immunol 2001; 2: 932-938.
5. Revy P, Sospedra M, Barbour B, Trautmann A. Functional antigen-independent synapses formed between T cells and dendritic cells. Nat Immunol 2001; 2: 925-931.
6. Geijtenbeek TB, Torensma R, van-Vliet SJ, van-Duijnhoven GCF, Adema GJ, van-Kooyk Y. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports immune responses. Cell 2000; 100: 575-585
7. Montoya MC, et al. Role of ICAM-3 in the initial interaction of T lymphocytes and APCs. Nat Immunol 2002; 3: 159-168.
8. + T cells. Eur J Immunol 1995; 25: 2285-2294.
9. Starling GC, et al. Intercellular adhesion molecule-3 is the predominant co-stimulatory ligand for leukocyte function antigen-1 on human blood dendritic cells. Eur J Immunol 1995; 25: 2528-2532.
10. Damle NK, Klussman K, Aruffo A. Intercellular adhesion molecule-2, a second counterreceptor for CD11a/CD18 (leukocyte function-associated antigen-1), provides a costimulatory signal for T cell receptor-initiated activation of human T cells. J Immunol 1992; 148: 665-671.
11. Pagés F, et al. Binding of phosphatidylinositol-3-OH kinase to CD28 is required for T-cell signaling. Nature 1994; 369: 327-329.
12. Woodhead VE, et al. Novel molecular mechanisms of dendritic cell-induced T cell activation. Int Immunol 2000; 12: 1051-1061.
13. Balaian LB, Moehler T, Montgomery AMP. The human neural cell adhesion molecule L1 functions as a costimulatory molecule in T cell activation. Eur J Immunol 2000; 30: 938-943.
14. Lechmann M, et al. The extracellular domain of CD83 inhibits dendritic cell-mediated T cell stimulation and binds to a ligand on dendritic cells. J Exp Med 2001; 194: 1813-1821.
15. + T lymphocytes. J Immunol 1992; 148: 1985-1992.
16. Egner W, Hock BD, Hart DNJ. Dendritic cells have reduced cell surface membrane glycoproteins including CD43 determinants. Adv Exp Med Biol 1993; 329: 71-73.
17. Ostberg JR, Barth RK, Frelinger JG. The Roman god Janus. a paradigm for the function of CD43. Immunol Today 1998; 19: 546-55O.
18. Steinman RM, Cohn ZA. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med 1973; 137: 1142-1162.
19. Al-Alwan MM, Rowden G, Lee TDG, West KA. The dendritic cell cytoskeleton is critical for the formation of the immunological synapse. J Immunol 2001; 166: 1452-1456.
20. Jenkins MK, et al. In vivo activation of antigen-specific CD4 T cells. Annu Rev Immunol 2001; 19: 23-45.
21. Garside P, Ingulli E, Merica R, Johnson JG, Noelle RJ, Jenkins MK. Visualization of specific B and T lymphocyte interactions in the lymph node. Science 1998; 281: 96-99.
22. Bishop GA, Hostager BS. B lymphocyte activation by contact-mediated interactions with T lymphocytes. Curr Opin Immunol 2001; 13: 278-285.
23. Sanders VM, Snyder JM, Uhr JW, Vitetta ES. Characterization of the physical interaction between antigen-specific B and T cells. J Immunol 1986; 137: 2395-2404.
24. Doyle C, Strominger J. Interaction between CD4 and class II MHC molecules mediates cell adhesion. Nature 1987; 330: 256-259.
25. Kruman I, Ramiya V, Bondada S. A role for T cell CD4 in contact mediated T dependent B cell activation. Cell Immunol 1996; 173: 236-245.
26. Moingeon PE, et al. Complementary roles for CD2 and LFA-1 adhesion pathways during T cell activation. Eur J Immunol 1991; 21: 605-610.
27. Mazzerolles F, Lumbroso C, Lecomte O, Le-Deist F, Ficher A. The role of lymphocyte function-associated antigen 1 (LFA-1) in the adherence of T lymphocytes to B lymphocytes. Eur J Immunol 1988; 18: 1229-1234.
28. Tohma S, Hiroata S, Lipsky PE. The role of CD11a/CD18-CD54 interactions in human T cell dependent B cell activation. J Immunol 1991; 146: 492-499.
29. + T cell adhesion to B cells. Cell Immunol 1994; 158: 376-388.
30. Aversa G, Chang C-CJ, Carballido JM, Cocks BG, de Vries JE. Engagement of the signaling lymphocytic activation molecule (SLAM) on activated T cells results in IL-2 independent, cyclosporin A-sensitive T cell proliferation and IFN-γ production. J Immunol 1997; 158: 4036-4044.
31. Sayos J, et al. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature 1998; 395: 462-469.
32. Mavaddat N, et al. Signaling lymphocytic activation molecule (CDw150) is homophilic but self associates with very low affinity. J Biol Chem 2000; 275: 28100-28109.
33. Martin M, et al. CD84 functions as a homophilic adhesion molecule and enhances IFN-γ secretion: adhesion is mediated by Ig-like domain 1. J Immunol 2001; 167: 3668-3676.
34. Tedder TF, Tuscano J, Sato S, Kehrl JH. CD22, a B lymphocyte-specific adhesion molecule that regulates antigen receptor signaling. Annu Rev Immunol 1997; 15: 481-504.
35. Sgroi D, Varki A, Braesch-Andersen S, Stamenkovic I. CD22, a B cell specific immunoglobulin superfamily member, is a sialic acid binding lectin. J Biol Chem 1993; 268: 7011-7018.
36. Powell LD, Sgroi D, Sjoberg E, Stamenkovic I, Varki A. Natural ligands of the B cell adhesion molecule CD22 carry N-linked oligosaccharides with a-2,6-linked sialic acids that are required for recognition. J Biol Chem 1993; 268: 7019-78027.
37. Engel P, Wagner N, Miller A, Tredder TF. Identification of the ligand binding domains of CD22, a member of the immunoglobulin superfamily that uniquely binds a sialic acid dependent ligand. J Exp Med 1995; 181: 1581-1586.
38. Sgroi D, Koretzki G, Stamenkovic I. Regulation of CD45 engagement by the B cell receptor CD22. Proc Nad Acad Sci USA 1995; 92: 4026-4030.
39. Tuscano J, Engel P, Tredder TF, Kehrl JH. Engagement of the adhesion receptor CD22 triggers a potent stimulatory signal for B cells and blocking CD22/CD22L interactions impairs T-cell proliferation. Blood 1996; 87: 4723-4730.
40. Zinkernagel RM, Bachmann MF, Kundig TM, Oehen S, Pircher H, Hengartner H. On immunological memory. Annu Rev Immunol 1996; 14: 333.
41. Bierer BE, Sleckman BP, Ratnofsky SE, Burakoff SJ. The biologic roles of CD2, CD4, and CD8 in T-cell activation. Annu Rev Immunol 1989; 7: 579-599.
42. Davignon D, Martz E, Reynolds T, Kuerzinger K, Springer TA. Lymphocyte function antigen 1 (LFA-1): a surface antigen distinct from Lyt-2,3 that participates in T lymphocyte-mediated killing. Proc Natl Acad Sci USA 1981; 78: 4535.
43. Krensky AM, Robbins E, Springer TA, Burakoff SJ. LFA-1, LFA-2, and LFA-3 antigens are involved in CTL-target conjugation. J Immunol 1984; 131: 611.
44. Dustin ML, Springer TA. T cell receptor cross-linking transiently stimulates adhesiveness through, LFA-1 Nature 1989; 341: 619-624.
45. Yin D, et al. Ligation of CD28 in vivo induces CD40 ligand expression and promotes B cell survival. J Immunol 1999; 163: 4328-4334.
46. Bancroft GJ. The role of natural killer cells in innate resistance to infection. Curr Opin Immunol 1993; 5: 503.CHECK PAGES.
47. Davis DM, Chiu I, Fassett M, Cohen GB, Strominger JL. The human natural killer cell immune synapse. Proc Natl Acad Sci USA 1999; 96: 15062-15067.
48. Ljunggren HG, Karre K. In search of the 'missing self': MCH molecules and NK cell recognition. Immunol Today 1990; 11: 237-244.
49. Long EO, Rajagopalan S. HLA class I recognition by killer cell Ig-like receptors. Semin Immunol 2000; 12: 101-108.
50. Lanier LL. NK cell receptors. Annu Rev Immunol 1998; 16: 359-393.
51. Carbone E, et al. A new mechanism of NK cell cytotoxicity activation: the CD40-CD40 ligand interaction. J Exp Med 1997; 185: 2053.
52. Hildreth JEK, Gotch FM, Hildreth PDK, McMichael AJ. A human lymphocyte-associated antigen involved in cell-mediated lympholysis. Eur J Immunol 1983; 13: 202.
53. Matsumoto G, Nghiem MP, Nozaki N, Schmits R, Penninger JM. Cooperation between CD44 and LFA-1/CD11a adhesion receptors in lymphokine-activated killer cell cytotoxicity. J Immunol 1998; 160: 5781-5789.
54. Burshtyn DN, Shin J, Stebbins C, Long EO. Adhesion to target cells is disrupted by the killer cell inhibitory receptor. Curr Biol 2000; 10: 777-780.
55. Helander TS, Carpen O, Turunen O, Kovanen PE, Vaheri A, Timonen T. ICAM-2 redistributed by ezrin as a target for killer cells. Nature 1996; 382: 265-268.
56. Frey M, et al. Differential expression and function of 1-selectin on CD56bright and CD56dim natural killer cell subsets. J Immunol 1998; 161: 400-408.
57. Andre P, et al. Modification of P-selectin glycoprotein ligand-1 with a natural killer cell-restricted sulfated lactosamine creates an alternate ligand for 1-selectin. Proc Natl Acad Sci USA 2000; 97: 3400-3405.
58. Butcher EC, Picker LJ. Lymphocyte homing and homeostasis. Science 1996; 272: 60-66.
59. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994; 76: 301-314.
60. Nieto M, Frade JM, Sancho D, Mellado M, Martinez AC, Sanchez-Madrid F. Polarization of chemokine receptors to the leading edge during lymphocyte chemotaxis. J Exp Med 1997; 186: 153-158.
61. Vicente-Manzanares M, et al. The chemokine SDF-1 alpha triggers a chemotactic response and induces cell polarization in human B lymphocytes. Eur J Immunol 1998; 28: 2197-2207.
62. Pelletier AJ, et al. Presentation of chemokine SDF-1α by fibronectin mediates directed migration of T cells. Blood 2000; 96: 2682-2690.
63. Singer II, et al. CCR5, CXCR4, and CD4 are clustered and closely apposed on microvilli of human macrophages and T cells. J Virol 2001; 75: 3779-3790.
64. Vicente-Manzanares M, et al. A role for the Rho-p160 Rho coiled-coil kinase axis in the chemokine stromal cell-derived factor-1a-induced lymphocyte actomyosin and microtubular reorganization and chemotaxis. J Immunol 2002; 168: 400-410.
65. del Pozo MA, Sanchez-Mateos P, Nieto M, Sanchez-Madrid F. Chemokines regulate cellular polarization and adhesion receptor redistribution during lymphocyte interaction with endothelium and extracellular matrix. Involvement of cAMP signaling pathway. J Cell Biol 1995; 131: 495-508.
66. Ratner S, Sherrod WS, Lichlyter D. Microtubule retraction into the uropod and its role in T cell polarization and motility. J Immunol 1997; 159:
67. Brown MJ, Hallam JA, Colucci-Guyon E, Shaw S. Rigidity of circulating lymphocytes is primarily conferred by vimentin intermediate filaments. J Immunol 2001; 166: 6640-6646.
68. Serrador J, et al. Moesin interacts with the cytoplasmic region of ICAM-3 and is redistributed to the uropod of T lymphocytes during cell polarization. J Cell Biol 1997; 138: 1409-1423.
69. Serrador JM, et al. A juxtamembrane aminoacid sequence of PSGL-1 is involved in moesin binding and ERM-directed targeting at the trailing edge of migrating lymphocytes. Eur J Immunol 2002: in press.
70. del Pozo MA, Cabanas C, Montoya MC, Ager A, Sanchez-Mateos P, Sanchez-Madrid F. ICAMs redistributed by chemokines to cellular uropods as a mechanism for recruitment of T lymphocytes. J Cell Biol 1997; 137: 493-508.
71. Millan J, Montoya MC, Sancho D, Sánchez-Madrid F, Alonso MA. Lipid rafts mediate biosynthetic transport to the T lymphocyte uropod subdomain and are necessary for uropod integrity and function. Blood 2002; 99: 978-984.
72. Gomez-Moutón C, et al. Segregation of leading edge and uropod components into specific lipid rafts during T cell polarization. Proc Natl Acad Sci USA 2001; 98: 9642-9647.
73. Springer TA, Dustin ML, Kishimoto TK, Marlin SD. The lymphocyte function-associated LFA-1, CD2, and LFA-3 molecules: cell adhesion receptors of the immune system. Annu Rev Immunol 1987; 5: 223-252
74. Shaw AS, Dustin ML. Making the T cell receptor go the distance, a topological view of T cell activation. Immunity 1997; 6: 361-369.
75. Adam SM, et al. T-cell-receptor affinity and thymocyte positive selection. Nature 1996; 381: 616-620.
76. Corr M, et al. T cell receptor-MHC class I peptide interactions: affinity, kinetics, specificity. Science 1994; 265: 946-949.
77. Matsui K, Boniface JJ, Steffner P, Reay PA, Davis MM. Kinetics of T-cell receptor binding to peptide/I-Ek complexes: correlation of the dissociation rate with T-cell responsiveness. Proc Natl Acad Sci USA 1994; 91: 12862-12866.
78. Dermotz S, Grey HM, Sette A. The minimal number of class II MHC-antigen complexes needed for T cell activation. Science 1990; 249: 1028-1030.
79. Harding CV, Unanue ER. Quantitation of antigen presenting cell MHC class II/peptide complexes necessary for T cell stimulation. Nature 1990; 346: 574-576.
80. van-der-Merwe PA, Barclay AN. Transient intercellular adhesion, the importance of weak protein-protein interactions. Trends Biol Sci 1994; 19: 354-360.
81. Dustin ML, Ferguson ML, Chan PY, Springer TA, Golan D. Visualization of CD2 interaction with LFA-3 and determination of the two-dimensional dissociation constant for adhesion receptors in a contact area. J Cell Biol 1996; 132: 465-474.
82. Wyss DF, et al. Conformation and function of the N linked glycan in the adhesion domain of human CD2. Science 1995; 269: 1273-1278.
83. Chan PY, Springer TA. Effect of lengthening lymphocyte-function associated 3 on adhesion to CD2. Mol Biol Cell 1992; 3: 157-166.
84. Binnerts ME, van-Kooyk Y. How LFA-1 binds to different ligands. Immunol Today 1999; 20: 240-245.
85. van-Kooyk Y, Figdor CG. Avidity regulation of integrins: the driving force in leukocyte adhesion. Curr Opin Cell Biol 2000; 12: 542-547.
86. Dustin ML, Cooper JA. The immunological synapse and the actin cytoskeleton: molecular hardware for T cell signaling. Nat Immunol 2000; 1: 23-29.
87. Lollo BA, Chan KWH, Hanson EM, Moy VT, Brian AA. Direct evidence for two affinity states for lymphocyte function-associated antigen-1 on activated T cells. J Biol Chem 1993; 268: 21693-21700.
88. de-Fougerolles AR, Springer TA. Intercellular adhesion molecule 3, a third adhesion counter-receptor for lymphocyte function-associated molecule 1 on resting lymphocytes. J Exp Med 1992; 175: 185-190.
89. Hernandez-Caselles T, et al. ICAM-3, the third LFA-1 counterreceptor, is a co-stimulatory molecule for both resting and activated T lymphocytes. Eur J Immunol 1993; 23: 2799-2806.
90. Campanero MR, et al. ICAM-3 interacts with LFA-1 and regulates the LFA-1/ICAM-1 cell adhesion pathway. J Cell Biol 1993; 123: 1007-1016.
91. Juan M, et al. CD50 (intercellular adhesion molecule 3) stimulation induces calcium mobilization and tyrosine phosphorylation through p59 (fyn) and p56 (lck) in Jurkat T cell line. J Exp Med 1994; 179: 1747-1756.
92. Bleijs DA, de-Waal-Malefyt R, Figdor CG, van-Kooyk Y. Co-stimulation of T cells results in distinct IL-10 and TNF-alpha cytokine profiles dependent on binding to ICAM-1, ICAM-2 or ICAM-3. Eur J Immunol 1999; 29: 2248-2258.
93. de-Fougerolles AR, Qin X, Springer TA. Characterization of the function of intercellular adhesion molecule ICAM-3 and comparison with ICAM-1 and ICAM-2 in immune responses. J Exp Med 1994; 179: 619-629.
94. Fawcett J, et al. Molecular cloning of ICAM-3 a third ligand for LFA-1, constitutively expressed on resting leukocytes. Nature 1992; 360: 481-484.
95. van-Kooyk Y, van der Wiel P, van Kemenade I, Weder P, Kuijpers TW, Figdor CG. Enhancement of LFA-1 mediated cell adhesion by triggering through CD2 or CD3 on T lymphocytes. Nature 1989; 342: 811-813.
96. Donnadieu E, Bismuth G, Trautmann A. Antigen recognition by helper T cells elicits a sequence of distinct changes of their shape and intracellular calcium. Curr Biol 1994; 4: 584-595.
97. Negulescu PA, Krasieva TB, Khan A, Kerschbaum HH, Cahalan MD. Polarity of T cell shape, motility and sensitivity to antigen. Immunity 1996; 4: 421-430.
98. + T cells compulsory cytoskeletal alterations for the triggering of an intracellular calcium response. Eur J Immunol 1998; 28: 716-729.
99. 2+ responses triggered in T cells by dendritic cells compared with B cells. J Exp Med 1998; 188: 1473-1484.
100. Dustin ML, Bromley SK, Kan Z, Peterson DA, Unanue DR. Antigen receptor engagement delivers a stop signal to migrating T lymphocytes. Proc Natl Acad Sci USA 1997; 94: 3909-3913.
101. Delon J, Germain R. Information transfer at the Immunological synapse. Curr Biol 2000; 10: R923-R933.
102. Dustin ML, Chan AC. Signaling takes shape in the immune system. Cell 2000; 103: 283-294.
103. van-der-Merwe PA, Davis SJ, Shaw AS, Dustin ML. Cytoskeletal polarization and redistribution of cell-surface molecules during T cell antigen recognition. Semin Immunol 2000; 12: 5-21.
104. Lanzavecchia A, Sallusto F. Antigen decoding by T lymphocytes: from synapses to fate determination. Nat Immunol 2001; 2: 487-492.
105. Monks CRF, Freiberg BA, Kupfer H, Sclaky N, Kupfer A. Three-dimensional segregation of supramolecular activation clusters in T cells. Nature 1998; 395: 82-86.
106. Krummel MF, Sjaastad MD, Wülfing C, Davis MM. Differential clustering of CD4 and CD3 during T cell recognition. Science 2000; 289: 1349-1352.
107. Grakoui A, et al. The immunological synapse: a molecular machine controlling T cell activation. Science 1999; 285: 221-227.
108. Leupin O, Zaru R, Laroche T, Muller S, Valitutti S. Exclusion of CD45 from the T-cell receptor signaling area in antigen-stimulated T lymphocytes. Curr Biol 2000; 10: 277-280.
109. Johnson KG, Bromley SK, Dustin ML, LTM. A supramolecular basis for CD45 tyrosine phosphatase regulation in sustained T cell activation. Proc Natl Acad Sci USA 2000; 97: 10138-10143.
110. Sperling AI, Sedy JR. Manjunath N. Kupfer A, Ardman B, Burkhardt JK. TCR signaling induces selective exclusion of CD43 from the T cell-antigen-presenting cell contact site. J Immunol 1998; 161: 6459-6462.
111. Roumier A, et al. The membrane microfilament linker Ezrin is involved in the formation of the immunological synapse and in T cell activation. Immunity 2001; 15: 715-728.
112. Delon J, Kaibuchi K, Germain R. Exclusion of CD43 from the immunological synapse is mediated by phosphorylation-regulated relocation of the cytoskeletal adaptor moesin. Immunity 2001; 15: 691-701.
113. Allenspach EJ, et al. ERM-dependent movement of CD43 defines a novel protein complex distal to the immunological synapse. Immunity 2001; 15: 739-750.
114. Kupfer A, Swain SL, Singer SJ. The specific direct interaction of helper T cells and antigen presenting B cells. II. Reorientation of the microtubule organizing center and reorganization of the membrane-associated cytoskeleton inside the bound helper. J Exp Med 1987; 165: 1565-1580.
115. Lee KH, Holdorf AD, Dustin ML, Chan AC, Allen PM, Shaw AS. T cell receptor signaling precedes immunological synapse formation. Science 2002; 295: 1539-1542.
116. Davis SJ, van der Merwe PA. The immunological synapse: required for T cell receptor signaling or directing T cell effector function. Curr Biol 2001; 11: R289-R291.
117. Rothstein TL, Mage M, Jones G, McHugh LL. Cytotoxic T lymphocyte sequential killing of immobilized allogeneic tumor target cells measured by time-lapse microcinematography. J Immunol 1978; 121: 1652-1656.
118. Kupfer A, Singer SJ. Cell biology of cytotoxic and helper T cell functions: immunofluorescence microscopic studies of single cells and cell couples. Annu Rev Immunol 1989; 7: 309-337.
119. Huang JF, et al. TCR-mediated internalization of peptide-MHC complexes acquired by T cells. Science 1999; 286: 952-954.
120. Hudrisier D, Riond J, Mazarguil H, Gairin JE, Joly E. CTLs rapidly capture membrane fragments from target cells in a TCR signaling-dependent manner. J Immunol 2001; 166: 3645-3649.
121. Stinchcombe JC, Bossi G, Booth S, Griffiths GM. The immunological synapse of CTL contains a secretory domain and membrane bridges. Immunity 2001; 15: 751-761.
122. Boyington JC, Motyka AS, Schuck P, Brooks AG, Sun PD. Crystal structure of an NK cell immunoglobulln-like receptor in complex with its class I MHC ligand. Nature 2000; 405: 537-543.
123. Eriksson M, Ryan JC, Nakamura MC, Sentman CL. Ly49A inhibitory receptors redistribute on natural killer cells during target cell interaction. Immunology 1999; 2: 341.
124. Fassett M, Davis DM, Valter MM, Cohen GB, Strominger JL. Signaling at the inhibitory natural killer cell immune synapse regulates lipid raft polarization but not class-I MHC clustering. Proc Natl Acad Sci USA 2001; 98: 14547-14552.
125. Binstadt BA, et al. Sequential involvement of Lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation. Immunity 1996; 5: 629-638.
126. Vyas YM, et al. Spatial organization of signal transduction molecules in the NK cell immune synapses during MHC class I-regulated noncytolytic and cytolytic interactions. J Immunol 2001; 167: 4358-4367.
127. Sancho D, et al. The tyrosine kinase PYK-2/RAFTK regulates natural killer (NK) cell cytotoxic response, and is translocated and activated upon specific cell recognition and killing. J Cell Biol 2000; 149: 1249-1261.
128. Batista FD, Iber D, Neuberger MS. B cells acquire antigens from target cells after synapse formation. Nature 2001; 411: 489-494.
129. Wild MK, et al. Dependence of T cell antigen recognition on the dimensions of an accessory receptor-ligand complex. J Exp Med 1999; 190: 31-41.
130. Qi SY, Groves JT, Chakraborty AK. Synaptic pattern formation during cellular recognition. Proc Natl Acad Sci USA 2001; 98: 6548-6553.
131. Horejsi V, et al, GPI-microdomains: a role in signaling via immunoreceptors. Immunol Today 1999; 20: 356-361.
132. Langlet C, Bernard A-M, Drevot P, He H-T. Membrane rafts and signaling by the multichain immune recognition receptors. Curr Opin Immunol 2000; 12: 250-255.
133. Xavier R, Seed B. Membrane compartmentation and the response to antigen. Curr Opin Immunol 1999; 11: 265-269.
134. Arcaro A, et al. Essential role of CD8 palmitoylation in CD8 coreceptor function. J Immunol 2000:
135. Rodgers W, Rose JK. Exclusion of CD45 inhibits activity of p56lck associated with glycolipid-enriched membrane domains. J Cell Biol 1996; 135: 1515-1523.
136. Xavier R, Brennan T, Li Q, McCormack C, Seed B. Membrane compartmentalization is required for efficient T cell activation. Immunity 1998; 8: 723-732.
137. Zhang W, Trible RP, Samelson L.E. LAT palmitoylation: its essential role in membrane microdomain targeting and tyrosine phosphorylation during T cell activation. Immunity 1998; 9: 239-246.
138. Brdicka T, Cerny J, Horejsi V. T cell receptor signaling results in rapid tyrosine phosphorylation of the linker protein LAT present in detergent-resistant membrane microdomains. Biochem Biophys Res Commun 1998; 248: 356-360.
139. Kawabuchi M, et al. Transmembrane phosphoprotein Cbp regulates the activities of Src-family tyrosine kinases. Nature 2000; 404: 999-1003.
140. Bi K, et al. Antigen-induced translocation of PKC-θ to membrane rafts is required for T cell activation. Nat Immunol 2001; 2: 556-563.
141. Montixi C, et al. Engagement of T cell receptor triggers its recruitment to low density detergent-insoluble membrane domains. EMBO J 1998; 17: 5334-5348.
142. Moran M, Miceli MC. Engagement of GPI-linked CD48 contributes to TCR signals and cytoskeletal reorganization: a role for lipid rafts in T cell activation. Immunity 1998; 9: 787-796.
143. Kabouridis PS, Janzen J, Magee AL, Ley SC. Cholesterol depletion disrupts lipid rafts and modulates the activity of multiple signaling pathways in T lymphocytes. Eur J Immunol 2000; 30: 954-963.
144. Janes PW, Ley SC, Magee AI. Aggregation of lipid rafts accompanies signaling via the T cell antigen receptor. J Cell Biol 1999; 147: 447-461.
145. Tousto L, Parolini I, Schroeder S, Sargiacomo M, Lanzavecchia A, Viola A. Organization of plasma membrane functional rafts upon T cell activation. Eur J Immunol 2001; 31: 345-349.
146. Viola A, Schroeder S, Sakakibara M, Lanzavecchia A. T lymphocyte costimulation mediated by reorganization of membrane microdomains. Science 1999; 283: 680-682.
147. Yashiro-Ohtani Y, et al. Non-CD28 costimulatory molecules present in T cell rafts induce T cell costimulation by enhancing the association of TCR with rafts. J Immunol 2000; 164: 1251-1259.
148. Krauss K, Altevoght P. Integrin leukocyte function-associated antigen-1-mediated cell binding can be activated by clustering of membrane rafts. J Biol Chem 1999; 274: 36921-36927.
149. Turley SJ, et al. Transport of peptide-MHC class II complexes in developing dendritic cells. Science 2000; 288: 522-527.
150. Szollosi J, Horejsi V, Bene L, Angelisova P, Damjanovich S. Supramolecular complexes of MHC class I, MHC class II, CD20, and tetraspan molecules (CD53, CD81, and CD82) at the surface of a B cell line JY. J Immunol 1996; 157: 2939-2946.
151. Vereb G, et al. Cholesterol-dependent clustering of IL-2R alpha and its colocalization with HLA and CD48 on T lymphoma cells suggest their functional association with lipid rafts. Proc Natl Acad Sci USA 2000; 97: 6013-6018.
152. Anderson HA, Hitbold EM, Roche PA. Concentration of MHC class II molecules in lipid rafts facilitates antigen presentation. Nat Immunol 2000; 1: 156-161.
153. Kropshofer H, et al. Tetraspan microdomains distinct from lipid rafts enrich select peptide-MHC class II complexes. Nat Immunol 2002; 3: 61-68.
154. Valitutti S, Dessing M, Aktories K, Gallati H, Lanzavecchia A. Sustained signaling leading to T cell activation results from prolonged T cell receptor occupacy. Role of T cell actin cytoskeleton. J Exp Med 1995; 181: 577-584.
155. Wulfing C, Sjaastad MD, Davis MM. Visualizing the dynamics of T cell activation: intracellular adhesion molecule 1 migrates rapidly to the T cell-B cell interface and acts to sustain calcium levels. Proc Natl Acad Sci USA 1998; 95: 6302-6307.
156. Wulfing C, Davis MM. A receptor/cytoskeletal movement triggered by costimulation during T cell activation. Science 1998; 282: 2266-2269.
157. Sampath R, Gallagher PJ, Pavalko FM. Cytoskeletal interactions with the leukocyte integrin β2 cytoplasmic tail. Activation-dependent regulation of associations with talin and α-actinin. J Biol Chem 1998; 273: 33588-33594.
158. Dustin ML, et al. A novel adaptor protein that orchestrates receptor patterning and cytoskeletal polarity in T-cell contacts. Cell 1998; 94: 667-677.
159. Samelson LE, Phillips AF, Luong ET, Klausner RD. Association of the Fyn protein-tyrosine kinase with the T-cell antigen receptor. Proc Natl Acad Sci USA 1990; 87: 4358-4362.
160. Krause M, Sechi AS, Konradt M, Monner D, Gertler FB, Wehland J. Fyn-binding protein (Fyb) /SLP76-associated protein (SLAP), Ena/Vasodilator-stimulated phosphoprotein (VASP) proteins and the Atp2/3 complex link T cell receptor (TCR) signaling to the actin cytoskeleton. J Cell Biol 2000; 149: 181-194.
161. Bretscher A, Chambers D, Nguyen R, Reczek D. ERM-Merlin and EBP50 protein families in plasma membrane organization and function. Annu Rev Cell Dev Biol 2000; 16: 113-143.
162. Yonemura S, Nagafuchi A, Sato N, Tsukita S. Concentration of an integral membrane protein, CD43 (leucosialin/sialophorin), in the cleavage furrow through the interactions of its cytoplasmic domain with actin based cytoskeleton. J Cell Biol 1993; 120: 437-449.
163. Yonemura S, Hirao M, Doi M, Takahashi SM, Kondo T, Tsukita S. Ezrin/radixin/moesin (ERM) proteins bind to a cytoplasmic domain of CD44, CD43, and ICAM-2. J Cell Biol 1998; 140: 885-895.
164. Serrador JM, et al. CD43 interacts with moesin and ezrin and regulates its redistribution to the uropods of T lymphocytes at the cell-cell contacts. Blood 1998; 91: 4632-4644.
165. Heiska L, Alfthan K, Gronholm M, Vilja P. Vaheri A, Carpen O. Association of ezrin with intracellular adhesion molecule-1 and -2 (ICAM-1 and ICAM-2). Regulation by phosphatidylinositol 4, 5-biphosphate. J Biol Chem 1998; 273: 21893-21900.
166. Serrador JM, et al. A novel serine-rich motif in the intercellular adhesion molecule 3 is critical for its ERM-directed subcellular targeting. J Biol Chem 2002: in press.
167. Itoh K, et al. Negative regulation of immune synapse formation by anchoring lipid raft to cytoskeleton through Cbp-EBP50-ERM assembly. J Immunol 2002; 168: 541-544.
168. Friedl P, Gunzer M. Interaction of T cells with APCs: the serial encounter model. Trends Immunol 2001; 22: 187-191.
169. Dustin ML, Allen PM, Shaw AS. Environmental control of immunological synapse formation and duration. Trends Immunol 2001; 22: 192-194.
170. Weiss A, Shields R, Newton M, Manger B, Imboden J. Ligand-receptor interactions required for commitment to the activation of the interleukin 2 gene. J Immunol 1987; 138: 2169-2176.
171. Cantrell DA, Smith KA. The interleukin-2 T cell system: a new cell growth model. Science 1984; 224: 1312-1316.
172. Gunzer M, et al. Antigen presentation in extracellular matrix. interactions of T cells with dendritic cells are dynamic, short lived, and sequential. Immunity 2000; 13: 323-332.
173. Berke G. The binding and lysis of target cells by cytotoxic lymphocytes: molecular and cellular aspects. Annu Rev Immunol 1994; 12: 735-773.
174. Bromley SK, Peterson DA, Gunn MD, Dustin ML. Hierarchy of chemokine receptor and TCR signals regulating T cell migration and proliferation. J Immunol 2000; 165: 15-19.
175. Reynolds PS, Shimizu Y, Mobley JL. Lymphocytes and extracellular matrix. In: Shimizu Y, ed. Lymphocyte Adhesion Molecules. Austin: CRC Press, 1993: 192-220.
176. Viola A, Lanzavecchia A. T cell activation determined by T cell receptor number and tunable thresholds. Science 1996; 273: 104-106.